As of November 14, 2026, LifeMD, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 18, 2026 (Form 8-K, March 18, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like LifeMD, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
LifeMD, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-18. Every row below is cited to the filing it comes from, and this page adds each new change as LifeMD, Inc. files it.
Also on the record for LifeMD, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 7, 2026 | Stake report, Schedule 13G/A, by Federated Hermes, Inc. | 8.4% of the class | 5%+ stakes | Source |
| July 8, 2026 | Stake report, Schedule 13G, by Federated Hermes, Inc. | 5.68% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs LifeMD, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on LifeMD, Inc. and the records around it.
Companies that share a holder
- Federated Hermes, Inc. also filed stake reports on 13 other companies: EyePoint (Nov 2026), Arcturus Therapeutics Holdings Inc. (Oct 2026), Forte Biosciences, Inc. (Sep 2026)
Watch LifeMD, Inc.
Get an email when LifeMD, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on LifeMD, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on LifeMD, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on LifeMD, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-18 | Reported | not named in the filing | 8-K, 2026-03-18 |
New leaders reset buying decisions — get the Full Report on LifeMD, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at LifeMD, Inc., with the record behind each one.
Find candidates like senior executive at LifeMD, Inc.Every change, in the filing's words
Reported
CFO Resignation On March 16, 2026, LifeMD, Inc ("LifeMD" or the "Company") announced that its Chief Financial Officer Marc Benathen will be departing LifeMD to pursue a new opportunity.
- Mr. Benathen will remain employed with LifeMD through March 31, 2026, to facilitate a smooth transition in the CFO role.
- In connection with this transition, the Company and Mr. Benathen entered into a Resignation & Transition Services Agreement, pursuant to which Mr. Benathen has agreed to provide transition advisory services to the Company for six to twelve months after his employment ends, and he will receive a service fee of $38,117 a month.
- Mr. Benathen will forfeit restricted stock units ("RSUs") that remain unvested as of March 31, 2026, and subject to the Company's Incentive Compensation Recovery Policy, will retain all RSUs vested prior to that date.
- The Company will reimburse Mr. Benathen for personal costs of COBRA benefits for a period ending no later than April 1, 2027.
- Mr. Benathen did not resign as a result of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
- The Company thanks Mr. Benathen for his service as Chief Financial Officer and his many other contributions to the Company.
- CFO Appointment On March 16, 2026, the Company publicly announced the appointment of Atul Kavthekar as its new Chief Financial Officer, effective on that date.
Tools for this story
Each opens in a new tab, filled in for LifeMD, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
